Once the golden child of the weight-loss boom, the Danish drugmaker now faces a painful financial slimming of its own.

Eli Lilly's stock dipped after drug trial results, but strong Q2 2025 earnings and market position make it a strong buy. Read ...

Eli Lilly & Co has experienced a significant stock price decline of 18.64% over the past week, largely due to disappointing ...

A new weight loss pill has been shown to help slimmers lose around 12 per cent of their body weight over 72 weeks. Alongside ...

A London-based consultant plastic and cosmetic surgeon, has warned of a mistake those on weight loss jabs can make that could ...